Bank of New York Mellon Corp - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 119 filers reported holding BIOXCEL THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$323,896
-57.0%
128,022
+13.2%
0.00%
Q2 2023$753,386
-47.7%
113,121
+46.7%
0.00%
Q1 2023$1,439,283
-6.9%
77,132
+7.2%
0.00%
Q4 2022$1,545,465
+100.4%
71,949
+10.3%
0.00%
Q3 2022$771,000
-3.9%
65,219
+7.3%
0.00%
Q2 2022$802,000
-34.3%
60,809
+4.1%
0.00%
Q1 2022$1,220,000
+5.7%
58,386
+2.9%
0.00%
Q4 2021$1,154,000
-29.8%
56,749
+4.8%
0.00%
Q3 2021$1,645,000
+14.0%
54,171
+9.1%
0.00%
Q2 2021$1,443,000
-44.7%
49,669
-17.9%
0.00%
-100.0%
Q1 2021$2,609,000
-8.6%
60,484
-2.2%
0.00%0.0%
Q4 2020$2,856,000
+18.5%
61,820
+11.2%
0.00%0.0%
Q3 2020$2,410,000
-13.3%
55,597
+6.0%
0.00%0.0%
Q2 2020$2,780,000
+149.3%
52,453
+5.2%
0.00%
Q1 2020$1,115,000
+292.6%
49,854
+156.7%
0.00%
Q4 2019$284,000
+107.3%
19,4230.0%0.00%
Q3 2019$137,000
-30.8%
19,423
+7.4%
0.00%
Q2 2019$198,00018,0830.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Logos Global Management LP 430,000$19,866,0001.70%
APIS CAPITAL ADVISORS, LLC 20,000$924,0000.89%
Avidity Partners Management LP 547,000$25,271,0000.82%
Knoll Capital Management, LLC 20,000$924,0000.63%
Artemis Investment Management LLP 1,013,448$46,839,0000.49%
AlphaCentric Advisors LLC 25,000$1,155,0000.48%
First Light Asset Management, LLC 94,202$4,352,0000.32%
Ikarian Capital, LLC 150,000$6,930,0000.31%
Longitude (Cayman) Ltd. 8,000$370,0000.18%
AllSquare Wealth Management LLC 5,490$254,0000.17%
View complete list of BIOXCEL THERAPEUTICS INC shareholders